BioCentury | Dec 19, 2013
Distillery Therapeutics

Indication: Infectious disease

...for licensing through UCL Business plc Contact: Abigail Watts, UCL Business plc, London, U.K. e-mail: a.watts@uclb.com...
BioCentury | Mar 15, 2012
Distillery Techniques

Technology: Markers

...Contact: Carol Harty, UCL Business plc, London, U.K. phone: +44 (0) 20 7679 9000 e-mail: c.harty@uclb.com...
BioCentury | Aug 1, 2011
Company News

March Medical Group, National Centre for Young People with Epilepsy, University College London deal

...subsidiary exclusive, worldwide rights to commercialize Epistatus buccal midazolam maleate to treat acute prolonged seizures. UCLB...
BioCentury | Jun 30, 2011
Distillery Techniques

Technology: Drug platforms

...Chris Williams, University College London Business plc, London, U.K. phone: +44 (0)20 7679 9000 e-mail: c.williams@uclb.com...
Items per page:
1 - 4 of 4
BioCentury | Dec 19, 2013
Distillery Therapeutics

Indication: Infectious disease

...for licensing through UCL Business plc Contact: Abigail Watts, UCL Business plc, London, U.K. e-mail: a.watts@uclb.com...
BioCentury | Mar 15, 2012
Distillery Techniques

Technology: Markers

...Contact: Carol Harty, UCL Business plc, London, U.K. phone: +44 (0) 20 7679 9000 e-mail: c.harty@uclb.com...
BioCentury | Aug 1, 2011
Company News

March Medical Group, National Centre for Young People with Epilepsy, University College London deal

...subsidiary exclusive, worldwide rights to commercialize Epistatus buccal midazolam maleate to treat acute prolonged seizures. UCLB...
BioCentury | Jun 30, 2011
Distillery Techniques

Technology: Drug platforms

...Chris Williams, University College London Business plc, London, U.K. phone: +44 (0)20 7679 9000 e-mail: c.williams@uclb.com...
Items per page:
1 - 4 of 4